In addition to the well-known antioxidant, anti-inflammatory, and anti-aggregation activities, it has also been shown that carnosine is able to reduce advanced glycation end products (AGEs) and tumor necrosis factor-α (TNF-α) levels in patients with type 2 diabetes mellitus (T2DM) [77]. The gene discussed is TNF; the disease is diabetes mellitus.